Hypaque-Cysto and Mogamulizumab
Determining the interaction of Hypaque-Cysto and Mogamulizumab and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: diatrizoate
Brand name: Cystografin, Cystografin-Dilute, Gastrografin, MD-76 R, MD-Gastroview
Synonyms: Diatrizoate Meglumine
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hypaque-Cysto-Mogamulizumab-kpkc
- Hypaque-Cysto-Mogamulizumab-kpkc Intravenous
- Hypaque-Cysto-Molindone
- Hypaque-Cysto-Mometasone (Oral Inhalation)
- Hypaque-Cysto-Mometasone and Formoterol
- Hypaque-Cysto-Mometasone and formoterol Inhalation
- Mogamulizumab-Hyper-Sal inhalation
- Mogamulizumab-Hyperhep B
- Mogamulizumab-HyperHEP B S/D
- Mogamulizumab-Hyperlyte CR
- Mogamulizumab-HyperRAB
- Mogamulizumab-HyperRAB human